Quantitative PET may improve staging, predict survival in NSCLC

05/1/2013 | MolecularImaging.net

Volumetric data from quantitative PET scans may help improve staging and provide data about survival in patients with non-small cell lung carcinoma, according to a study published in the American Journal of Roentgenology. Researchers conducted PET segmentation of total glycolytic activity using the gradient method, maximum standardized uptake value and metabolic tumor volume, in combination with other methods. At 12-month follow-up, 19 patients had survived while 20 had died, and those who died demonstrated an increase in mean metabolic tumor volume and gradient-based total glycolytic activity, the study said. Bigger studies are needed to validate the findings, researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC